培训课件-糖尿病肾病的诊断与治疗B.ppt

培训课件-糖尿病肾病的诊断与治疗B.ppt

  1. 1、本文档共77页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
* * * * * * * * * * * * * * * * * * Because hypertension and dyslipidaemia tend to be co-morbid with type 2 diabetes, true treatment to target is not a matter of glycaemic control only. A multifactorial intervention is needed. The study from the Steno Diabetes Center in Denmark proves that optimal management in type 2 diabetes includes control of BP to 130/80 mmHg and reduction of LDL cholesterol. Patients were randomised to either conventional (n = 80) or intensive treatment (n = 80). Intensive treatment included insulin to control HbA1C to 6.5%, a diuretic to control BP, and an ACE inhibitor, regardless of BP level. Additional therapies were as follows: Intensive treatment: an angiotensin II receptor blocker to control BP to 130/80 mmHg, dietary management of serum lipids (cholesterol: 190 mg/dl; fasting triglycerides: 150 mg/dl), and aspirin 150 mg/day. Conventional treatment: BP control to 135/85 mm Hg and serum lipid control (cholesterol 250 mg/dl; fasting triglycerides 180 mg/dl), with aspirin therapy reserved for patients with known ischaemia. Gaede P et al. N Engl J Med 2003; 348: 383–93. * * * * * * * * * * * * DN肾病的形成是一个渐进的过程,早期特征性改变是肾小球、肾小管细胞肥大,肾小球毛细血管基底膜增厚,继之细胞外基质形成增多,肾小球硬化和小管间质纤维化。 * * * * Microalbuminuria is a strong predictor of all-cause mortality and cardiovascular morbidity and mortality in type 2 diabetes. The impact of microalbuminuria on mortality was investigated in a 10-year follow-up study of 503 predominantly type 2 diabetic patients.1 265 of the patients died, and 58% of the deaths were caused by cardiovascular (CV) disease. Compared with patients with normal morning urinary albumin concentration (UAC ? 15 μg/min), the relative risk of death for patients with UAC between 15 and 40 μg/min and for patients with UAC between 41 and 200 μg/min were 1.53 and 2.28, respectively. Thus, the probability of survival decreased with increasing levels of UAC within the microalbuminuria range. Microalbuminuria was demonstrated to be a major

文档评论(0)

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档